Ryan Hanson
Family Medicine · Columbus, OHNPI 1891769006
Payments from drug & device makers
Across 251 payments — averaging $24.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Lilly USA, LLC$358
- Napo Pharmaceuticals Inc$312
- Theratechnologies Inc.$212
- Johnson & Johnson$200
- plus $1K from 16 others
What the payments were for
- Food & beverage$6,11299%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 90 | $2,508 |
| Gilead | 64 | $1,529 |
| Lilly USA, LLC | 10 | $358 |
| Napo Pharmaceuticals Inc | 16 | $312 |
| Theratechnologies Inc. | 12 | $212 |
| Johnson & Johnson | 11 | $200 |
| AbbVie | 11 | $200 |
| Merck | 7 | $148 |
| Antares Pharma, Inc. | 4 | $91 |
| Novo Nordisk | 5 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $78 |
| Organon | 1 | $78 |
| Verity Pharmaceuticals Inc. | 3 | $65 |
| Boehringer Ingelheim | 2 | $59 |
| Exact Sciences | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Corium, LLC | 1 | $33 |
| Janssen Products, LP | 1 | $30 |
| EMD Serono, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| GSK | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,153 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DescovyEmtricitabine/Tenofov Alafenam | 37 | $76,569 |
| MounjaroTirzepatide | 28 | $29,131 |
| TivicayDolutegravir Sodium | 13 | $25,954 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,546 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $931 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 15 | $876 |
| Bupropion XlBupropion Hcl | 14 | $368 |
| Omeprazole | 25 | $314 |
| Cyclobenzaprine Hcl | 12 | $252 |
| Gabapentin | 18 | $248 |
| Terbinafine Hcl | 13 | $138 |
| Atorvastatin Calcium | 13 | $87 |
| Losartan Potassium | 21 | $76 |
| Fluticasone Propionate | 13 | $67 |
| Amlodipine Besylate | 24 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadDescovy | $1,529 | $76,56937 claims |
| Lilly USA, LLCMounjaro | $358 | $29,13128 claims |
| Viiv Healthcare CompanyTivicay | $2,508 | $25,95413 claims |
| GSKTrelegy Ellipta | $23 | $10,54617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Columbus
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
- Robert FloreaColumbus$955K
- Bryan FeldmanColumbus$404K
- Scott MerrymanColumbus$89K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.